Valneva SE (VALN) Short term Debt (2020 - 2026)
Valneva SE (VALN) posted quarterly Short term Debt of $20.8 million for Q1 2026, down 7.28% year-on-year from $22.4 million in Q1 2025, and up 2.04% on a QoQ basis from $20.4 million in Q4 2025.
Valneva SE (VALN) Short term Debt (2020 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Short term Debt for 7 consecutive years, with $20.8 million the latest figure, recorded in Q1 2026.
- Quarterly Short term Debt fell 7.28% year-over-year to $20.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.8 million (down 7.28% YoY) and the FY2025 annual result came in at $20.4 million, down 14.13% from the prior year.
- Short term Debt grew to $20.8 million in Q1 2026 per VALN's latest filing, from $20.4 million in the prior quarter.
- Over the last five years, Short term Debt for VALN reached as high as $66.9 million in Q3 2025 and fell as low as $13.1 million in Q2 2022.
- A 5-year average of $27.0 million and a median of $22.4 million in 2025 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2023 — Short term Debt surged 280.65% — and 2024, when it tumbled 52.69%.
- Year by year, Short term Debt stood at $13.2 million in 2022, then jumped by 280.65% to $50.2 million in 2023, then slumped by 52.69% to $23.7 million in 2024, then dropped by 14.13% to $20.4 million in 2025, then rose by 2.04% to $20.8 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $20.8 million, $20.4 million, and $66.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.79 Mn |
| Dec 31, 2025 | 20.38 Mn |
| Sep 30, 2025 | 66.95 Mn |
| Jun 30, 2025 | 52.37 Mn |
| Mar 31, 2025 | 22.42 Mn |
| Dec 31, 2024 | 23.73 Mn |
| Sep 30, 2024 | 22.14 Mn |
| Jun 30, 2024 | 22.61 Mn |
| Mar 31, 2024 | 25.50 Mn |
| Dec 31, 2023 | 50.16 Mn |
| Sep 30, 2023 | 38.48 Mn |
| Jun 30, 2023 | 24.12 Mn |
| Mar 31, 2023 | 16.11 Mn |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | 14.22 Mn |
| Jun 30, 2022 | 13.14 Mn |
| Mar 31, 2022 | 13.35 Mn |
| Dec 31, 2021 | 8.09 Mn |
| Dec 31, 2020 | 7.95 Mn |